Pediatric allergy and immunology in Japan

Motohiro Ebisawa1, Sankei Nishima, Hidenori Ohnishi

  • 1Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan.

Insights

The Japanese Society of Pediatric Allergy and Clinical Immunology has advanced pediatric asthma and food allergy care through guidelines and oral immunotherapy. Recent data suggests a slight decrease in childhood asthma prevalence in Japan.

Area of Science:

  • Pediatric Allergy and Clinical Immunology
  • Immunology
  • Pediatrics

Background:

  • The Japanese Society of Pediatric Allergy and Clinical Immunology (JSPACI) was established in 1966 to address the rising prevalence of pediatric allergic diseases in Japan.
  • Guidelines for pediatric asthma and food allergy management have been developed and revised by JSPACI since 2000 and 2005, respectively.
  • The prevalence of allergic diseases, including wheezing and food allergies, has increased significantly over the past five decades, although recent data indicates a potential decrease in asthma prevalence.

Purpose of the Study:

  • To provide an overview of the Japanese Society of Pediatric Allergy and Clinical Immunology's contributions to pediatric allergy and immunology.
  • To highlight advancements in the management of pediatric asthma and food allergies in Japan.
  • To discuss current research trends in primary immunodeficiency syndromes and immunotherapy.

Main Methods:

  • Review of guidelines and training programs established by JSPACI and the Japanese Society of Pediatrics.
  • Analysis of prevalence data from surveys on childhood asthma and allergies.
  • Examination of trends in the diagnosis and treatment of primary immunodeficiency syndromes.

Main Results:

  • JSPACI has developed and regularly revised asthma guidelines since 2000, improving pediatric asthma control.
  • Food allergy management guidelines were introduced in 2005, enhancing patient care. Over 50 facilities offer oral immunotherapy for food allergies.
  • While asthma prevalence showed a multi-year increase, the latest data from 2012 suggests a slight decrease. Food allergy prevalence is estimated at 5-10% in infants and 1-2% in schoolchildren.
  • Research is expanding beyond antibody defects to include acquired and innate immune disorders.

Conclusions:

  • The JSPACI plays a crucial role in advancing pediatric allergy and clinical immunology in Japan through guideline development and training.
  • Oral immunotherapy is increasingly utilized for food allergies, while research into primary immunodeficiency syndromes is broadening.
  • There is a need to re-evaluate and develop subcutaneous and sublingual immunotherapies for environmental allergens like mites and Japanese cedar pollen.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
26.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
293